Apollo Biowellness Inc (KOAN) Stock Price & News

All values in USD	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Revenue	656.23K	598.63K	546.31K	430.77K
Cost of goods sold	266.72K	179.16K	182.94K	140.72K
Cost of revenue	266.72K	179.16K	182.94K	140.72K
Research and development expenses	-	3.51K	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.10M	685.72K	714.03K	620.28K
Operating expense	1.10M	689.23K	714.03K	620.28K
Total operating expenses	1.36M	868.38K	896.97K	761.01K
Operating income	-708.63K	-269.76K	-350.66K	-330.24K
Other non operating income	-	-	3.37K	215.00
EBT including unusual items	-708.63K	-305.50K	-577.44K	-411.82K
EBT excluding unusual items	-708.63K	-273.04K	-577.44K	-411.82K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-708.63K	-305.50K	-577.44K	-411.82K
Net profit margin	-107.99%	-51.03%	-105.70%	-95.60%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-3.28K	-230.15K	-81.79K
Net interest expenses	-	-3.28K	-230.15K	-81.79K
Depreciation and amortization charges	-	-	-	-
EBITDA	-693.39K	-269.76K	-350.66K	-325.96K
Gain or loss from assets sale	69.24K	69.24K	-	-

AI content may include mistakes. Learn more

Finance